CD163 and non-small cell lung carcinoma: In this study, we found that the percentages of MDSCs as well as CD68+CD163+M2-like macrophages of NSCLC patients in RT and post-RT were elevated in NSCLC patients without metastasis but were not significantly increased in NSCLC patients with metastasis.